What is the incidence of anaphylaxis in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Incidence of Anaphylaxis in Pregnancy

The incidence of anaphylaxis in pregnancy is rare, occurring in approximately 1.6 per 100,000 maternities (95% CI: 1.1-2.2), with severe perioperative obstetric anaphylaxis occurring at 1-3.5 per 100,000 deliveries. 1, 2

Epidemiological Data

The most robust population-based data comes from the UK Obstetric Surveillance System (UKOSS) study, which prospectively identified 37 confirmed cases of anaphylaxis over a 3-year period (2012-2015) among pregnant women in the UK 2. This translates to the incidence of 1.6 per 100,000 maternities, making it an uncommon but serious complication.

When specifically examining perioperative obstetric anaphylaxis (occurring during cesarean delivery or labor procedures), the RCOG Green-top Guideline reports an incidence range of 1-3.5 per 100,000 1. This slightly higher range reflects the increased exposure to potential allergens during surgical and anesthetic procedures.

Clinical Context and Triggers

The majority of anaphylaxis cases in pregnancy are drug-related, particularly:

  • Antibiotics (most common): In the UKOSS study, 12 women developed anaphylaxis following prophylactic antibiotics at cesarean delivery 2
  • Penicillins and cephalosporins: Four cases occurred in women with known penicillin allergies who received co-amoxiclav or cephalosporins 2
  • Anesthetic agents: Common during perioperative period 1
  • Other triggers include latex, animal allergens, and foods 1

Mortality and Morbidity

Despite the low incidence, anaphylaxis carries significant mortality risk with approximately 1% mortality rate 1. The UKOSS study documented:

  • 2 maternal deaths (5% case fatality rate) 2
  • 38% required intensive care admission 2
  • 19% experienced additional severe maternal morbidities including cardiac arrests, hemorrhagic events, and thrombotic complications 2

Fetal/Neonatal Impact

Among infants whose mothers experienced anaphylaxis before delivery:

  • 41% required neonatal intensive care admission 2
  • Three preterm births occurred 2
  • One infant required therapeutic cooling for neonatal encephalopathy 2
  • No neonatal deaths were reported in this cohort 2

Important Clinical Caveats

Diagnostic challenges exist because normal physiological changes in pregnancy (hypotension, tachycardia) can mask or mimic anaphylaxis symptoms 1. Additionally, cutaneous manifestations may be less prominent in pregnant women, making recognition more difficult.

The data emphasizes that while anaphylaxis is rare, the consequences are severe when it occurs, particularly given the dual risk to both mother and fetus. The predominance of antibiotic-related cases highlights the importance of careful allergy history documentation before administering prophylactic antibiotics during delivery procedures.

References

Guideline

maternal collapse in pregnancy and the puerperium: green-top guideline no. 56.

BJOG : an international journal of obstetrics and gynaecology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.